Cargando…

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies

The objective of this study is to explore the following: (1) the impact of two different initial doses and cumulative 2-year dose of rituximab (RTX) on drug adherence and predictors of adherence to treatment in rheumatoid arthritis (RA) patients in an observational clinical setting, (2) immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einarsson, Jon Thorkell, Evert, Max, Geborek, Pierre, Saxne, Tore, Lundgren, Maria, Kapetanovic, Meliha C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681601/ https://www.ncbi.nlm.nih.gov/pubmed/28980088 http://dx.doi.org/10.1007/s10067-017-3848-6

Ejemplares similares

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
por: Nived, Per, et al.
Publicado: (2018)

Predictors of infusion reactions during infliximab treatment in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2006)

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2014)

Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2011)

The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients
por: Nagel, Johanna, et al.
Publicado: (2015)

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003)

Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
por: Kristensen, Lars Erik, et al.
Publicado: (2006)

Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients – baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice
por: Wallman, Johan K., et al.
Publicado: (2015)

Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
por: Gülfe, Anders, et al.
Publicado: (2009)

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
por: Nived, Per, et al.
Publicado: (2020)

Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
por: Nived, Per, et al.
Publicado: (2020)

Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
por: Kapetanovic, Meliha C, et al.
Publicado: (2016)

EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry
por: Jørgensen, Tanja Schjødt, et al.
Publicado: (2017)

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012)

Circulating complexes between tumour necrosis factor‐alpha and etanercept predict long‐term efficacy of etanercept in juvenile idiopathic arthritis
por: Kahn, Robin, et al.
Publicado: (2016)

A novel statistical method for assessing effective adherence to medication and calculating optimal drug dosages
por: Greene, Garrett, et al.
Publicado: (2018)

Personalized Drug Dosage – Closing the Loop
por: Tucker, Geoffrey T
Publicado: (2016)

The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience
por: Nissen, Johanna C, et al.
Publicado: (2014)

Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions
por: Alaibac, Mauro
Publicado: (2018)

Pharmaceutical dosage forms and drug delivery systems /
por: Ansel, Howard C., 1933-
Publicado: (1999)

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)

The effects of rituximab on serum IgE and BAFF
por: Dasgupta, Angira, et al.
Publicado: (2013)

Automatic identification and normalization of dosage forms in drug monographs
por: Li, Jiao, et al.
Publicado: (2012)

Ophthalmic Drug Dosage Forms: Characterisation and Research Methods
por: Baranowski, Przemysław, et al.
Publicado: (2014)

Effects of maternal psychotropic drug dosage on birth outcomes
por: Michielsen, Laura A, et al.
Publicado: (2013)

Drug-associated cues and drug dosage contribute to increased opioid seeking after abstinence
por: Zanda, Mary Tresa, et al.
Publicado: (2021)

Linear IgA bullous dermatosis treated with rituximab
por: Pinard, Camille, et al.
Publicado: (2019)

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
por: Wincup, Chris, et al.
Publicado: (2022)

The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis
por: Roseman, Carmen, et al.
Publicado: (2012)

Drug, dosage, activity, studies of antimalarials by physical methods - II
por: Murthy, Vedam Rama, et al.
Publicado: (2007)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Lower rate of acceptable knee function in adolescents compared with young adults five years after acl reconstruction: results from the swedish national knee ligament register
por: Thorolfsson, Baldur, et al.
Publicado: (2022)

Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
por: Wallwork, Rachel, et al.
Publicado: (2018)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate
por: Herbener, Peter, et al.
Publicado: (2018)

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis
por: Faustini, Francesca, et al.
Publicado: (2021)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia
por: Wang, Zhibin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gq80neocjjs4e4dfa93vklhj96